Search Results - "Cifrián Martínez, José M."
-
1
Serological Biomarkers in Individuals with Interstitial Lung Disease after SARS-CoV-2 Infection and Association with Post-COVID-19 Symptoms
Published in Pathogens (Basel) (31-07-2024)“…Patients with interstitial lung disease (ILD) represent a vulnerable population against an acute SARS-CoV-2 infection. It has been observed that up to 80% of…”
Get full text
Journal Article -
2
Osteopontin as a Biomarker in Interstitial Lung Diseases
Published in Biomedicines (01-05-2024)“…Osteopontin (OPN) is a glycoprotein involved in Th1 and Th17 differentiation, and inflammation and tissue remodeling. OPN is a biomarker of disease activity in…”
Get full text
Journal Article -
3
Evaluating Sensitization-associated, Neuropathic-like Symptoms and Psychological Factors in Patients With Interstitial Lung Disease
Published in The journal of pain (01-09-2024)“…The aims of this study were to phenotype pain in patients with interstitial lung disease (ILD) by investigating the association between…”
Get more information
Journal Article -
4
Bronchial Stenosis After Lung Transplantation From cDCD Donors Using Simultaneous Abdominal Normothermic Regional Perfusion: A Single-center Experience
Published in Transplantation (01-11-2023)“…Controlled donation after circulatory death (cDCD) has increased the number of lung donors significantly. The use of abdominal normothermic regional perfusion…”
Get full text
Journal Article -
5
The impact of time from ILD diagnosis to referral to the transplant center on the probability of inclusion in the transplant waiting list
Published in Heart & lung (01-09-2024)“…•ILD are one of the main indications for lung transplantation.•Early referral to transplant units of patients with ILD favors their inclusion on the waiting…”
Get full text
Journal Article -
6
Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients
Published in Heart, lung & circulation (01-04-2024)“…Pulmonary hypertension (PH) secondary to lung disease (Group-3 PH) is the second leading cause of PH. The role of PH as a risk factor for primary graft…”
Get full text
Journal Article -
7
Exacerbation of chronic renal failure because of inhaled tobramycin in a lung transplant patient
Published in Respiratory medicine case reports (01-01-2022)“…61-year-old man, with a history of years of unknown etiology bronchiectasis, with chronic bronchial infection by Burkholderia multivorans, who received…”
Get full text
Journal Article -
8
DQA1 Eplet Mismatch Load As an Independent Risk Factor of CLAD After Lung Transplantation
Published in Transplantation direct (01-07-2023)“…Lung transplantation remains the treatment of choice for end-stage lung diseases, and recipient selection is currently based on clinical urgency, ABO…”
Get full text
Journal Article -
9